Related references
Note: Only part of the references are listed.Antidepressants and health-related quality of life (HRQoL) for patients with depression: Analysis of the medical expenditure panel survey from the United States
Omar A. Almohammed et al.
PLOS ONE (2022)
Esketamine Nasal Spray for Rapid Reduction of Depressive Symptoms in Patients With Major Depressive Disorder Who Have Active Suicide Ideation With Intent: Results of a Phase 3, Double-Blind, Randomized Study (ASPIRE II)
Dawn F. Ionescu et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2021)
Antidepressant Paroxetine Exerts Developmental Neurotoxicity in an iPSC-Derived 3D Human Brain Model
Xiali Zhong et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial
Aristotle N. Voineskos et al.
JAMA PSYCHIATRY (2020)
When and how to use lithium
S. A. Barroilhet et al.
ACTA PSYCHIATRICA SCANDINAVICA (2020)
A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression
Paulo R. Shiroma et al.
TRANSLATIONAL PSYCHIATRY (2020)
Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development
Alice Egerton et al.
SCHIZOPHRENIA RESEARCH (2020)
The research evidence for schizophrenia as a neurodevelopmental disorder
Bjorn Rishovd Rund
SCANDINAVIAN JOURNAL OF PSYCHOLOGY (2018)
The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia
Donald C. Goff et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Maintenance efficacy designs in psychiatry: Randomized discontinuation trials - enriched but not better
S. N. Ghaemi et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL SCIENCE (2017)
BDNF as a biomarker for successful treatment of mood disorders: A systematic & quantitative meta-analysis
Maryna Polyakova et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
Long term sertraline effects on neural structures in depressed and nondepressed adult female nonhuman primates
Stephanie L. Willard et al.
NEUROPHARMACOLOGY (2015)
DSM-5 and the miracle that never happens
S. N. Ghaemi
ACTA PSYCHIATRICA SCANDINAVICA (2014)
The 'pragmatic' secret of DSM revisions
S. Nassir Ghaemi
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2014)
Review of Maintenance Trials for Major Depressive Disorder: A 25-Year Perspective From the US Food and Drug Administration
Silvana Borges et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Debating DSM-5: diagnosis and the sociology of critique
Martyn D. Pickersgill
JOURNAL OF MEDICAL ETHICS (2014)
Relapse Duration, Treatment Intensity, and Brain Tissue Loss in Schizophrenia: A Prospective Longitudinal MRI Study
Nancy C. Andreasen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies
P. Fusar-Poli et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)
Taking disease seriously in DSM
S. Nassir Ghaemi
WORLD PSYCHIATRY (2013)
Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis
Andrea Cipriani et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Putting the efficacy of psychiatric and general medicine medication into perspective: review of meta-analyses
Stefan Leucht et al.
BRITISH JOURNAL OF PSYCHIATRY (2012)
THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA: An Historical and Philosophical Analysis
Kenneth S. Kendler et al.
PHILOSOPHY PSYCHIATRY & PSYCHOLOGY (2011)
Alzheimer's disease: strategies for disease modification
Martin Citron
NATURE REVIEWS DRUG DISCOVERY (2010)
How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
S. Leucht et al.
MOLECULAR PSYCHIATRY (2009)
Selective publication of antidepressant trials and its influence on apparent efficacy
Erick H. Turner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Initial severity and antidepressant benefits: A meta-analysis of data submitted to the food and drug administration
Irving Kirsch et al.
PLOS MEDICINE (2008)
Blood pressure reduction and cardiovascular outcomes: past, present, and future
Giuseppe Mancia
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Suicidality in pediatric patients treated with antidepressant drugs
TA Hammad et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Long-term lithium therapy for bipolar disorder: Systematic review and meta-analysis of randomized controlled trialls
JR Geddes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, bcl-2 and Cu/Zn-SOD in rat hippocampus
HY Xu et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Clozapine treatment for suicidality in schizophrenia - International Suicide Prevention Trial (InterSePT)
HY Meltzer et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Share Paper
